IMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, effective creating of digital structured reports for : adult catheterization and echocardiography, pediatric echocardiography, congenital heat disease, nuclear cardiology and non-invasive vascular disease management. This webb-based application allows cardiology departments to view, edit and sign the structured reports.
Published August 1, 2012 · Recall initiated: July 10, 2012
Summary
FDA records medical device Class II recall Z-2069-2012, published August 1, 2012 and initiated July 10, 2012. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: 6; Lot: Software Version: RM 2.03 to 2.08, NIV 1.0. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
When users selected "Left stenosis" in the "Graft Duplex Conclusion" section in IMPAX CV Reporting Non-Invasive(NIV) module, "Right stenosis" appeared in the sentence display within the printed representation of the report.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AGFA Corp.
- Distributor
- Nationwide Distribution including IN, SC, OH, TX
- Lot
- Software Version: RM 2.03 to 2.08, NIV 1.0
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAGFA Digital Radiography X-Ray system DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagnosticJuly 30, 2014
- FDAIMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR)June 4, 2014
- FDAIMPAX RIS QDOC 5.8February 12, 2014
- FDAIMPAX 5.2 DB Server (running Oracle 10.1.0.4.0), medical imaging Picture Archiving and Communication SystemOctober 30, 2013
- FDAVITROS 5600 Integrated System Software For use in the in-vitro quantitative, semi quantitative, andAugust 1, 2012
- FDAProduct is labeled in part: "***OPTETRAK***TIBIAL TRAY***TRAPEZOID CEMENTED***Ti Alloy*** SIZE 1F/1T,August 1, 2012
Questions about this recall
Was IMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, effective creating of digital structured reports for : adult catheterization and echocardiography, pediatric echocardiography, congenital heat disease, nuclear cardiology and non-invasive vascular disease management. This webb-based application allows cardiology departments to view, edit and sign the structured reports. recalled?
Yes. FDA published recall Z-2069-2012 on August 1, 2012. Reported hazard: When users selected "Left stenosis" in the "Graft Duplex Conclusion" section in IMPAX CV Reporting Non-Invasive(NIV) module, "Right stenosis" appeared in the sentence display within the printed representation of the report.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone